These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38847420)

  • 21. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results.
    Pibarot P; Delgado V; Bax JJ
    Eur Heart J Cardiovasc Imaging; 2019 Jun; 20(6):620-624. PubMed ID: 31115470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous Mitral-Valve Intervention for Secondary Mitral Regurgitation: Data From Real-Life.
    Kaddoura R; Al-Badriyeh D; Abushanab D; Al-Hijji M
    Curr Probl Cardiol; 2023 Oct; 48(10):101889. PubMed ID: 37336309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of preinterventional tricuspid regurgitation on outcome of MitraClip therapy in patients with severely reduced ejection fraction.
    Gyoten T; Messroghli D; Schenk S; Rochor K; Grimmig O; Just S; Fritzsche D
    Open Heart; 2020; 7(1):e001203. PubMed ID: 32201589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial.
    Kang DH; Park SJ; Shin SH; Hwang IC; Yoon YE; Kim HK; Kim M; Kim MS; Yun SC; Song JM; Kang SM
    Circulation; 2024 Jun; 149(24):1865-1874. PubMed ID: 38690659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MitraClip for secondary mitral regurgitation: Patient selection.
    Zalawadiya SK; Gonzales HM; Goel K; Lindenfeld J
    Prog Cardiovasc Dis; 2022; 73():67-75. PubMed ID: 35605697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MitraClip: How Do We Reconcile the Inconsistent Findings of MITRA-FR and COAPT?
    Mauricio R; Kumbhani DJ
    Curr Cardiol Rep; 2019 Nov; 21(12):150. PubMed ID: 31768771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of conventional surgery versus MitraClip® therapy for moderate to severe symptomatic mitral valve regurgitation in the elderly population: an institutional experience.
    Alozie A; Paranskaya L; Westphal B; Kaminski A; Sherif M; Sindt M; Kische S; Schubert J; Diedrich D; Ince H; Steinhoff G; Öner A
    BMC Cardiovasc Disord; 2017 Mar; 17(1):85. PubMed ID: 28320316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous MitraClip Device or Surgical Mitral Valve Repair in Patients With Primary Mitral Regurgitation Who Are Candidates for Surgery: Design and Rationale of the REPAIR MR Trial.
    McCarthy PM; Whisenant B; Asgar AW; Ailawadi G; Hermiller J; Williams M; Morse A; Rinaldi M; Grayburn P; Thomas JD; Martin R; Asch FM; Shu Y; Sundareswaran K; Moat N; Kar S
    J Am Heart Assoc; 2023 Feb; 12(4):e027504. PubMed ID: 36752231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive hemodynamics and cardiac biomarkers to predict outcomes after percutaneous edge-to-edge mitral valve repair in patients with severe heart failure.
    Kreusser MM; Geis NA; Berlin N; Greiner S; Pleger ST; Bekeredjian R; Katus HA; Raake PW
    Clin Res Cardiol; 2019 Apr; 108(4):375-387. PubMed ID: 30191296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System.
    Nickenig G; Hammerstingl C; Schueler R; Topilsky Y; Grayburn PA; Vahanian A; Messika-Zeitoun D; Urena Alcazar M; Baldus S; Volker R; Huntgeburth M; Alfieri O; Latib A; La Canna G; Agricola E; Colombo A; Kuck KH; Kreidel F; Frerker C; Tanner FC; Ben-Yehuda O; Maisano F
    JACC Cardiovasc Interv; 2016 Oct; 9(19):2039-2047. PubMed ID: 27712741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.
    Iung B; Armoiry X; Vahanian A; Boutitie F; Mewton N; Trochu JN; Lefèvre T; Messika-Zeitoun D; Guerin P; Cormier B; Brochet E; Thibault H; Himbert D; Thivolet S; Leurent G; Bonnet G; Donal E; Piriou N; Piot C; Habib G; Rouleau F; Carrié D; Nejjari M; Ohlmann P; Saint Etienne C; Leroux L; Gilard M; Samson G; Rioufol G; Maucort-Boulch D; Obadia JF;
    Eur J Heart Fail; 2019 Dec; 21(12):1619-1627. PubMed ID: 31476260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV; Chinnakondepalli KM; Spertus JA; Magnuson EA; Baron SJ; Kar S; Lim DS; Mishell JM; Abraham WT; Lindenfeld JA; Mack MJ; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2019 May; 73(17):2123-2132. PubMed ID: 30894288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter Mitral Valve Repair With MitraClip for Symptomatic Functional Mitral Valve Regurgitation.
    Mendirichaga R; Singh V; Blumer V; Rivera M; Rodriguez AP; Cohen MG; O'Neill WW; Elmariah S
    Am J Cardiol; 2017 Aug; 120(4):708-715. PubMed ID: 28645469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres.
    Kitamura M; Kaneko H; Schlüter M; Schewel D; Schmidt T; Alessandrini H; Kreidel F; Neuss M; Butter C; Kuck KH; Frerker C
    Clin Res Cardiol; 2019 Mar; 108(3):264-272. PubMed ID: 30097683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter "edge-to-edge" mitral valve repair: influence of bias in randomized trials.
    García-Villarreal OA
    Gac Med Mex; 2022; 158(5):323-327. PubMed ID: 36572051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of Death or HF Hospitalization in Patients With Severe FMR: The COAPT Risk Score.
    Shah N; Madhavan MV; Gray WA; Brener SJ; Ahmad Y; Lindenfeld J; Abraham WT; Grayburn PA; Kar S; Lim DS; Mishell JM; Whisenant BK; Zhang Z; Redfors B; Mack MJ; Stone GW
    JACC Cardiovasc Interv; 2022 Oct; 15(19):1893-1905. PubMed ID: 36202557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous repair of mitral valve regurgitation in patients with severe heart failure: comparison with optimal medical treatment.
    Geis N; Raake P; Lewening M; Mereles D; Chorianopoulos E; Frankenstein L; Katus HA; Bekeredjian R; Pleger ST
    Acta Cardiol; 2018 Aug; 73(4):378-386. PubMed ID: 29161956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in patient selection and devices for transcatheter edge-to-edge mitral valve repair in heart failure.
    Orban M; Lüsebrink E; Braun D; Stocker TJ; Bagaev E; Hagl C; Näbauer M; Massberg S; Orban M; Hausleiter J
    Expert Rev Med Devices; 2020 Feb; 17(2):93-102. PubMed ID: 31923376
    [No Abstract]   [Full Text] [Related]  

  • 39. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B; Cohen DJ; Ben-Yehuda O; Redfors B; Kar S; Lim DS; Arnold SV; Li Y; Lindenfeld J; Abraham WT; Mack MJ; Stone GW
    J Am Heart Assoc; 2023 Feb; 12(4):e028444. PubMed ID: 36752227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome comparison of mitral valve surgery and MitraClip therapy in patients with severely reduced left ventricular dysfunction.
    Gyoten T; Schenk S; Rochor K; Herwig V; Harnath A; Grimmig O; Just S; Fritzsche D; Messroghli D
    ESC Heart Fail; 2020 Aug; 7(4):1781-1790. PubMed ID: 32445540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.